OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
- Conditions
- Interventions
- First Posted Date
- 2018-01-08
- Last Posted Date
- 2024-11-20
- Target Recruit Count
- 601
- Registration Number
- NCT03393520
- Locations
- 🇺🇸
Advanced Research Center, Inc #835, Anaheim, California, United States
🇺🇸ATP Clinical Research, Inc #763, Costa Mesa, California, United States
🇺🇸Crystal Biomedical Research, LLC, Miami Lakes, Florida, United States
The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder
- Conditions
- Interventions
- First Posted Date
- 2017-10-27
- Last Posted Date
- 2021-10-29
- Target Recruit Count
- 239
- Registration Number
- NCT03324581
- Locations
- 🇺🇸
iResearch Atlanta, Decatur, Georgia, United States
🇺🇸Premier Psychiatric Research Institute, LLC, Lincoln, Nebraska, United States
🇺🇸Psychiatric Associates, Overland Park, Kansas, United States
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
- Conditions
- Interventions
- First Posted Date
- 2017-09-26
- Last Posted Date
- 2018-06-12
- Target Recruit Count
- 24
- Registration Number
- NCT03292848
- Locations
- 🇺🇸
Woodland Research Northwest, LLC, Rogers, Arkansas, United States
🇺🇸Alliance for Wellness dba Alliance for Research, Long Beach, California, United States
🇺🇸Cutting Edge Research Group, Oklahoma City, Oklahoma, United States
A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.
- First Posted Date
- 2017-09-19
- Last Posted Date
- 2020-08-17
- Target Recruit Count
- 381
- Registration Number
- NCT03287869
- Locations
- 🇺🇸
Woodland Research Northwest, LLC, Rogers, Arkansas, United States
🇧🇬"Mental Health Centre-Ruse" EOOD, Male department for persons with severe mental disorders, Female department for persons with severe mental disorders, Ruse, Bulgaria
🇵🇱Indywidualna Specjalistyczna Praktyka Lekarska Wieslaw Jerzy Cubala, Gdańsk, Poland
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder
- Conditions
- Interventions
- First Posted Date
- 2017-08-23
- Last Posted Date
- 2020-02-10
- Target Recruit Count
- 322
- Registration Number
- NCT03259555
- Locations
- 🇺🇸
Galiz Research, Hialeah, Florida, United States
🇺🇸Ci Trials, Riverside, California, United States
🇺🇸Richard H Weisler, MD, PA, and Associates, Raleigh, North Carolina, United States
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
- Conditions
- Interventions
- First Posted Date
- 2017-08-22
- Last Posted Date
- 2020-02-11
- Target Recruit Count
- 333
- Registration Number
- NCT03257865
- Locations
- 🇺🇸
CiTrials, Santa Ana, California, United States
🇺🇸Research Centers of America LLC, Hollywood, Florida, United States
🇺🇸CNRI-San Diego, San Diego, California, United States
Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia
- First Posted Date
- 2017-08-03
- Last Posted Date
- 2024-10-17
- Target Recruit Count
- 296
- Registration Number
- NCT03238326
- Locations
- 🇺🇸
For additional information regarding sites, contact 844-687-8522, Kinston, North Carolina, United States
Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia
- Conditions
- Interventions
- First Posted Date
- 2017-06-23
- Last Posted Date
- 2023-12-20
- Target Recruit Count
- 316
- Registration Number
- NCT03198078
- Locations
- 🇺🇸
For additional information regarding sites, contact 844-687-8522, Oklahoma City, Oklahoma, United States
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
- First Posted Date
- 2017-05-12
- Last Posted Date
- 2018-06-12
- Target Recruit Count
- 36
- Registration Number
- NCT03150771
- Locations
- 🇺🇸
Community Clinical Research Inc., Austin, Texas, United States
🇺🇸CNRI-San Diego, San Diego, California, United States
🇺🇸Woodland International Research Group, Little Rock, Arkansas, United States
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain Injury
- Conditions
- Interventions
- First Posted Date
- 2017-03-29
- Last Posted Date
- 2023-09-29
- Target Recruit Count
- 168
- Registration Number
- NCT03095066
- Locations
- 🇺🇸
Design Neuroscience Center, PL, Doral, Florida, United States
🇺🇸Meridien Research, Maitland, Florida, United States
🇺🇸Neurobehavioral Medicine Group #222, Bloomfield Hills, Michigan, United States